Tardive dyskinesia (TD) is a devastating adverse effect of long-term antipsychotic drug treatment. Atypical antipsychotics produce less TD, and it has been shown that they may have a therapeutic effect on pre-existing TD. Here, we report a case of olanzapine-induced TD which did not improve after switching to risperidone but improved after the addition of quetiapine to risperidone regimen. We also provide a brief review of the reported cases on TD induced by atypical antipsychotics which improved after switching to another atypical agent. It is unclear whether some atypical antipsychotics are more effective than others in the treatment of TD. Differences in this property and the underlying mechanism require further study.
Abbasian, C., Power, P (2009) A case of aripiprazole and tardive dyskinesia. J Psychopharmacol23: 214-215.
2.
Agarwal, V., Kumar, P. ( 2001) Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases. J Clin Psychiatry62: 298-299.
3.
Bai, YM, Yu, SC, Chen, JY, Lin, CY, Chou, P., Lin, CC ( 2005) Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study. Int Clin Psychopharmacol20: 79-85.
4.
Bai, YM, Yu, SC, Lin, CC ( 2003) Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry64: 1342-1348.
5.
Brar, JS, Parepally, H., Chalasani, L., Gopalani, A., Appel, N., Chengappa, KN ( 2008) The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population. Ann Clin Psychiatry20: 139-144.
6.
Bressan, RA, Jones, HM, Pilowsky, LS ( 2004) Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity. J Psychopharmacol18: 124-127.
7.
Carvalho, R., Silva, R., Abilio, V., Barbosa, P., Frussa-Filho, R. ( 2003) Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice. Brain Res Bull60: 115-124.
8.
Casey, D. ( 2004) Pathophysiology of drug-induced movement disorders. J Clin Psychiatry65 (Suppl. 9): 25-28.
9.
Chan, J., Sweeting, M. ( 2006) Combination therapy with nonclozapine atypical antipsychotic medication: a review of current evidence. J Psychopharmacol21: 657-664.
10.
Chen, JY, Bai, YM, Pyng, LY, Lin, CC ( 2001) Risperidone for tardive dyskinesia. Am J Psychiatry158: 1931-1932.
11.
Correll, CU, Leucht, S., Kane, JM ( 2004) Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry161: 414-425.
12.
Correll, CU, Schenk, EM ( 2008) Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry21: 151-156.
13.
Cortese, L., Caligiuri, MP, Williams, R., Schieldrop, P., Manchanda, R., Malla, A., et al. (2008) Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. J Clin Psychopharmacol28: 69-73.
14.
Duggal, H. ( 2003) Aripiprazole-induced improvement in tardive dyskinesia . Can J Psychiatry48: 771-772.
15.
Emsley, R., Turner, HJ, Schronen, J., Botha, K., Smit, R., Oosthuizen, P. ( 2004) A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia. J Clin Psychiatry65: 696-701.
16.
Farah, A. ( 2001) Reduction of tardive dyskinesia with quetiapine. Schizophr Res47: 309-310.
17.
Fountoulakis, K., Panagiotidis, P., Siamouli, M., Kantartzis, S., Mavridis, T., Iacovides, A., et al. (2006) Amisulpride-induced tardive dyskinesia. Schizophr Res88: 232-234.
18.
Gourzis, P., Polychronopoulos, P., Papapetropoulos, S., Assimakopoulos, K., Argyriou, A., Beratis, S. ( 2005) Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics. Clin Neuropharmacol28: 195-196.
19.
Ipekci, S., Birsoz, S. ( 2001) Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine . Eur Psychiatry16: 259-260.
20.
Jaffe, M., Simpson, G. ( 1999) Reduction of tardive dystonia with olanzapine. Am J Psychiatry156: 2016.
21.
Kantrowitz, J., Srihari, V., Tek, C. ( 2007) Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. J Clin Psychopharmacol27: 525-526.
22.
Kapur, S., Seeman, P. ( 2001) Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry158: 360-369.
23.
Khan, B. ( 1997) Brief report: risperidone for severely disturbed behaviour and tardive dyskinesia in developmentally disabled adults. J Autism Dev Disord27: 479-489.
24.
Kinon, B., Jeste, D., Kollack-Walker, S., Stauffer, V., Liu-Seifert, H. ( 2004) Olanzapine treatment for tardive dyskinesia in schizophrenic patients: a prospective clinical trial with patients randomized to blind dose reduction periods. Prog Neuropsychopharmacol Biol Psychiatry28: 985-996.
25.
Lapaz, AG, Fernandez, LG, Martinez, MJ ( 2003) Quetiapine treatment of risperidone-related tardive dyskinesia . A case report. Actas Esp Psiquiatr31: 306.
26.
Lieberman, JA, Saltz, BL, Johns, CA, Pollack, S., Borenstein, M., Kane, J. ( 1991) The effects of clozapine on tardive dyskinesia. Br J Psychiatry158: 503-510.
27.
Littrell, KH, Johnson, CG, Littrell, S., Peabody, CD ( 1998) Marked reduction of tardive dyskinesia with olanzapine . Arch Gen Psychiatry55: 279-280.
28.
Louza, M., Bassitt, D. ( 2005) Maintenance treatment of severe tardive dyskinesia with clozapine. J Clin Psychopharmacol25: 180-182.
29.
Lykouras, L., Agelopoulos, E., Tzavellas, E. ( 2002) Improvement of tardive dyskinesia following switch from neuroleptics to olanzapine. Prog NeuroPsychopharmacol Biol Psychiatry26: 815-817.
30.
Madhusoodanan, S., Brenner, R., Gupta, S., Reddy, H., Bogunovic, O. ( 2004) Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies. CNS Spectr9: 862-867.
31.
Margolese, H., Chouinard, G., Kolivakis, T., Beauclair, L., Miller, R., Annable, L. ( 2005) Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: incidence and management strategies in patients with schizophrenia. Can J Psychiatry50: 703-714.
32.
Mattay, V., Casey, D. ( 2003) Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. In: Hirsch, S, Weinberger, D (eds), Schizophrenia. Oxford: Blackwell Publishing, pp. 552-572.
33.
Nelson, M., Reynolds, R., Kelly, D., Conley, R. ( 2003) Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Clin Neuropharmacol26: 297-298.
34.
Peritogiannis, V., Tsouli, S., Zafiris, S., Pappas, D., Mavreas, V. ( 2006) Improvement of tardive dyskinesia following amisulpride treatment. Prog NeuroPsychopharmacol Biol Psychiatry30: 748-750.
35.
Perquin, L. ( 2005) Treatment with the new antipsychotic sertindole for late-occurring undesirable movement effects. Int Clin Psychopharmacol20: 335-338.
36.
Rizos, E., Douzenis, A., Gournellis, R., Christodoulou, C., Lykouras, L (2009) Tardive dyskinesia in a patient treated with quetiapine . World J Biol Psychiatry10: 54-57.
37.
Sacchetti, E., Valsecchi, P. ( 2003) Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first generation antipsychotics: a 124-week case report. Int Clin Psychopharmacol18: 357-359.
38.
Sharma, A., Ramaswamy, S., Dewan, V. ( 2005) Resolution of ziprasidone-related tardive dyskinesia with a switch to aripiprazole. Prim Care Companion J Clin Psychiatry7: 36.
39.
Tamminga, C., Thaker, G., Morah, M., Kakigi, T., Gao, X. ( 1994) Clozapine in tardive dyskinesia: observations from human and animal model studies. J Clin Psychiatry55 (Suppl. B): 102-106.
40.
Tarsy, D., Baldessarini, R. ( 2006) Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics. Mov Disord21: 589- 598.
41.
Witschy, J., Winter, S. ( 2005) Improvement in tardive dyskinesia with aripiprazole use . Can J Psychiatry50: 188.
42.
Yovtcheva, S., Stanley-Tilt, C., Moles, J. ( 2000) Reemergence of tardive dyskinesia after discontinuation of clozapine treatment. Schizophr Res46: 107-109.
